Biomarkers in Clozapine-responding Schizophrenia
NCT05316883
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Psychosis
Interventions
DRUG:
Clozapine
Sponsor
Jimmi Nielsen